Characterization and biodistribution of REGENXBIO NAV® platform capsids
Vložit
- čas přidán 8. 08. 2023
- Characterization and biodistribution of REGENXBIO NAV® platform capsids: under-employed gene therapy vector AAV7
Dr. Samantha Yost
Senior Scientist, REGENXBIO - Věda a technologie